Corixa Corp., of Seattle, appointed Gregory Sessler to its board.
Cortex Pharmaceuticals Inc., of Irvine, Calif., appointed Gary Tollefson to its board.
Corus Pharma, of Seattle, appointed Richard Brewer to its board.
EpiTan Ltd., of Melbourne, Australia, appointed Ella Toombs regulatory advisory consultant.
Invitrogen Corp., of Carlsbad, Calif., appointed Karen Gibson senior vice president of information technology and chief information officer and Nicholas Barthelemy senior vice president of global operations.
MDS Pharma Services, of Montreal, named Robert Beland senior vice president of discovery and preclinical, James Baumgartner technical director of pharmacology services for early stage development, Randy Atkinson manager of global clinical training and Ronald Norton site director for the Neptune, N.J., facility.
Millenia Hope Inc., of Montreal, appointed Jacky Quan executive vice president and treasurer.
Millenium Biologix Inc., of Kingston, Ontario, appointed Ian Malone chief financial officer.
Mtm Laboratories AG, of Heidelberg, Germany, added to its supervisory board Erich Platzer, Werner Schafer and Rainer Strohmenger.
Myriad Genetics Inc., of Salt Lake City, elected Dennis Langer and John Henderson to its board.
Oncolytics Biotech Inc., of Calgary, Alberta, appointed Jim Dinning to its board.
Osteotech Inc., of Eatontown, N.J., elected Stephen Galliker to its board.